Opportunity Information: Apply for RFA AG 24 042
The NIA Research and Entrepreneurial Development Immersion (REDI) Entrepreneurial Small Business Transition Award is a National Institutes of Health funding opportunity that uses the SBIR R43/R44 mechanism (clinical trial optional) to help early-career scientists move into industry while pushing a health-related product or technology forward. In practice, it is designed to do two things at once: build a stronger small business research and development team by bringing in talented postdoctoral fellows or early-stage researchers as the project leader, and intentionally develop that person into an entrepreneur through structured training, mentoring, and career development activities. The idea is that scientific talent often exists in academic settings, but translating discoveries into real-world products requires business experience, industry exposure, and commercialization skills; this program tries to close that gap by embedding entrepreneurial development directly into the grant-supported project.
A key feature of this FOA is that the small business applicant is expected to hire and support the salary of a postdoctoral fellow or early-stage investigator who will serve as the Principal Investigator/Program Director (PI/PD). That staffing model is central to the program: the award is not only funding R&D and product development, but also creating a pathway for a promising scientist to transition from a training-focused environment into a leadership role in a company setting. The FOA emphasizes candidates who already have strong research skills and technology discovery experience, but who also have a clear interest in growing their entrepreneurial skillset and building a career in industry. Alongside the technical aims, the application is expected to reflect a serious commitment to mentoring and entrepreneurial training for the PI/PD, making professional development an explicit and major component rather than an informal side benefit.
Administratively, this is a discretionary grant opportunity from the NIH, with the National Institute on Aging (NIA) as the sponsoring institute and a health-related activity category (CFDA 93.866). Eligible applicants are small businesses, consistent with SBIR program rules. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. However, foreign components as defined in the NIH Grants Policy Statement may be permitted in limited circumstances, which typically means certain discrete project elements could be performed outside the U.S. if they are well-justified and allowable under NIH policy.
The opportunity is identified as RFA-AG-24-042, and the original closing date listed is October 26, 2023. Overall, the program is best understood as an industry-development-oriented SBIR award that deliberately pairs early-career scientific leadership with commercialization-focused support, aiming to accelerate both the individual’s transition into an entrepreneurial role and the small business’s progress toward a viable aging-related health product, service, or technology (with clinical trials allowed but not required).Apply for RFA AG 24 042
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-08-15.
- Applicants must submit their applications by 2023-10-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: ACCES A L'EDUCATION / ACCESS TO EDUCATION (A2E)
Previous opportunity: F24AS00466 - FY 2024 Clean Vessel Act (CVA)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 24 042
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 24 042) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029 Funding Number: PAR 24 029 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001 Funding Number: 72065623APS00001 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $92,000,000 |
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258 Funding Number: PAR 23 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043 Funding Number: RFA AG 24 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027 Funding Number: RFA NS 24 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030 Funding Number: RFA NS 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290 Funding Number: PA 23 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291 Funding Number: PA 23 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274 Funding Number: PAR 23 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046 Funding Number: RFA AG 24 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162 Funding Number: RFA MH 24 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027 Funding Number: RFA AG 24 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012 Funding Number: RFA RM 23 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002 Funding Number: RFA HG 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031 Funding Number: RFA AG 24 031 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030 Funding Number: RFA AG 24 030 Agency: National Institutes of Health Category: Health Funding Amount: $2,750,000 |
| Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003 Funding Number: RFA DE 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Apply for PAR 22 268 Funding Number: PAR 22 268 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 055 Funding Number: RFA AI 23 055 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 004 Funding Number: RFA DE 24 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 042", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.